Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (431-440 of 1,137) with videos related to

Pageof 114
Sort By:
European Heart Journal|March 19, 2008
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapyMichelle O'Donoghue, David A Morrow, Christopher P Cannon, et al.
ESC Heart Failure|July 4, 2019
Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
ESC Heart Failure|July 4, 2019
Alteration of medical therapy in patients with heart failure relative to change in symptom severityNasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
Neurology|September 2, 2009
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke ProgramE E Smith, L Liang, A Hernandez, et al.
The American Journal of Cardiology|August 8, 2009
Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarctionYuri B Pride, Evan Appelbaum, Erin E Lord, et al.
The American Journal of Cardiology|April 26, 2008
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database)Nancy M Albert, Kimberly K Birtcher, Christopher P Cannon, et al.
The American Journal of Cardiology|June 21, 2006
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials)Hung Q Ly, Ajay J Kirtane, Sabina A Murphy, et al.
JAMA Cardiology|November 13, 2020
Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 InhibitionDaniel P Marcusa, Robert P Giugliano, Jeong-Gun Park, et al.
Heart (British Cardiac Society)|September 18, 2014
Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapyM Janzon, S James, C P Cannon, et al.
Results and Problems in Cell Differentiation|November 6, 2015
An Immune Effector System in the Protochordate Gut Sheds Light on Fundamental Aspects of Vertebrate ImmunityAssunta Liberti, Brittany Leigh, Rosaria De Santis, et al.
Pageof 114

Showing results (431-440 of 1,137) with videos related to

Sort By:
Pageof 114
European Heart Journal|March 19, 2008
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapyMichelle O'Donoghue, David A Morrow, Christopher P Cannon, et al.
ESC Heart Failure|July 4, 2019
Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
ESC Heart Failure|July 4, 2019
Alteration of medical therapy in patients with heart failure relative to change in symptom severityNasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
Neurology|September 2, 2009
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke ProgramE E Smith, L Liang, A Hernandez, et al.
The American Journal of Cardiology|August 8, 2009
Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarctionYuri B Pride, Evan Appelbaum, Erin E Lord, et al.
The American Journal of Cardiology|April 26, 2008
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database)Nancy M Albert, Kimberly K Birtcher, Christopher P Cannon, et al.
The American Journal of Cardiology|June 21, 2006
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials)Hung Q Ly, Ajay J Kirtane, Sabina A Murphy, et al.
JAMA Cardiology|November 13, 2020
Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 InhibitionDaniel P Marcusa, Robert P Giugliano, Jeong-Gun Park, et al.
Heart (British Cardiac Society)|September 18, 2014
Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapyM Janzon, S James, C P Cannon, et al.
Results and Problems in Cell Differentiation|November 6, 2015
An Immune Effector System in the Protochordate Gut Sheds Light on Fundamental Aspects of Vertebrate ImmunityAssunta Liberti, Brittany Leigh, Rosaria De Santis, et al.
Pageof 114